WISCONSIN (CoinChapter.com) — Today’s top stock gainer is Tupperware Brands Corp.’s stock (NYSE: TUP). Over the past month, the stock has risen nearly 300% as the company’s market capitalization has reached $137 million.
Why These Stocks Rallied
Tupperware Brands Corp. (NYSE: TUP)
In a surprising turn of events, Tupperware Brands Corp.’s stock (NYSE: TUP) saw a significant climb of 9.1% in Monday’s pre-market trades. This continues the rally the iconic container maker has been experiencing, despite its beleaguered state.
Last Friday saw the stock concluding the session up by 3.7%, contributing to an impressive overall rise of 277.9% within the past month. The company’s market capitalization reached $137 million on Friday, a substantial increase from $33 million on July 7, when Tupperware announced a waiver agreement with some creditors.
Archer Aviation Inc. (NYSE: ACHR)
Archer Aviation Inc. (NYSE: ACHR), a front-runner in the electric vertical takeoff and landing (eVTOL) aircraft industry, has announced a substantial expansion in its partnership with the Department of Defense.
The company has inked new contracts with the U.S. Air Force, cumulatively worth up to $142 million.
These U.S. Air Force and Archer contracts underscore the military’s appreciation for the revolutionary potential of Archer’s eVTOL aircraft and reinforce the importance of this technology for the nation’s Armed Forces.
The next phase will see Archer delivering up to six Midnight aircraft to the Air Force and sharing further flight test data.
GoodRx Holdings Inc. (NASDAQ: GDRX)
GoodRx Holdings, Inc. (NASDAQ: GDRX) saw a momentous surge today in its share price, marking a significant event in the stock market. The GoodRx Holdings stock jumped after the company received a rating upgrade from TD Cowen analyst Charles Rhyee.
The rating was elevated from Market Perform to Outperform, with a concurrent increase in the price target for GDRX from $6.5 to $12. This upgrade resulted in an impressive over 34% increase in GDRX shares with an exceptional trading volume. The trading session recorded a noteworthy activity, with over 12.8 million shares traded.
Symbotic Inc. (NASDAQ: SYM)
Symbotic Inc. (NASDAQ: SYM), a pioneering entity in the field of A.I.-enabled robotics technology for supply chain management, has released its Q3 Fiscal Year 2023 results.
The report shows that Symbotic recorded a revenue of $312 million but concurrently registered a net loss of $39 million and an adjusted EBITDA loss of $3 million for this quarter.
In comparison to the corresponding quarter from the previous fiscal year, the revenue has seen a significant rise from $176 million, despite an increased net loss. Furthermore, the company’s cash and cash equivalents, including restricted cash and marketable securities, have seen an increase of $48 million from the prior quarter.
AEON Biopharma Inc. (NASDAQ: AEON)
AEON Biopharma (NASDAQ: AEON) has announced the closing of its previously declared financing arrangements amounting to $125 million.
The funding encompasses approximately $50 million of committed financing, including $20 million of prior announced financing from existing and new AEON investors. Further, the cash balance in Priveterra’s trust account post-redemptions also contributes to this funding.
This committed financing has facilitated anticipation to yield sufficient proceeds to fund the company beyond the announcement of top-line data from its Phase 2 study with ABP-450.
